Greencore’s growing pains
It has been a hard grind for Greencore, but while uncertainty lies ahead, opportunity also knocks
Last week, two of Ireland’s mid-sized companies reported at the same time on the same day. Both UDG Healthcare and Greencore are listed on the FTSE 250, both have well-regarded management teams, both have pivoted towards the US market, and both have consistently grown in recent years.
But their share price performances over the past year were very different, with UDG’s shares rising by one third up to their results announcement last Tuesday, and Greencore’s...
Subscribe from just 1€
Choose the subscription that is right for you
For the first month
€19.99 Monthly ThereafterSubscribe today
For the first year
€199.99 annually thereafterSubscribe today
For the first 90 days
€55.00 quarterly ThereafterSubscribe today
These offers are not available for current subscribers. Offers and pricing are subject to change without notice.
Terms & Conditions Apply